Rain Oncology Inc. Common Stock
RAIN
RAIN was delisted on the 25th of January, 2024.
44 hedge funds and large institutions have $227M invested in Rain Oncology Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
10% more funds holding
Funds holding: 40 → 44 (+4)
0.46% more ownership
Funds ownership: 80.73% → 81.19% (+0.46%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $233M → $227M (-$6.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$17.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$669K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$447K |
| 4 |
State Street
Boston,
Massachusetts
|
+$399K |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$345K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.37M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.12M |
| 3 |
LM
Luminus Management
Houston,
Texas
|
-$4.9M |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$1.12M |
| 5 |
Janus Henderson Group
London,
|
-$862K |
RAIN Hedge Fund Activity: Q3 2021 in Review
44 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q3 2021, worth a combined $227M — down 2.7% from $233M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RAIN positions and 4 closed out — a net gain of 4 holders — while 14 added to existing stakes and 12 trimmed.
The largest buyer was BVF Inc, adding an estimated $17.3M. The largest seller was Logos Global Management, cutting an estimated $5.37M.
- 44 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q3 2021, up from 40 in Q2 2021.
- Funds reported $227M of Rain Oncology Inc. Common Stock stock for Q3 2021, down 2.7% quarter-over-quarter.
- 8 funds opened new Rain Oncology Inc. Common Stock positions in Q3 2021 and 4 closed out, a net change of +4 holders.
- The largest Rain Oncology Inc. Common Stock buyer in Q3 2021 was BVF Inc, an estimated $17.3M added.
- The largest Rain Oncology Inc. Common Stock seller in Q3 2021 was Logos Global Management, an estimated $5.37M sold.
Based on aggregated 13F filings for Q3 2021.